Baxter Reports Strong Second Quarter Financial Results Exceeding Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. IBM
5. MU
6. META
7. ACN
8. FDX
9. NVDA
10. BLZE

Go back to Baxter Reports Strong Second Quarter Financial Results Exceeding Guidance

Leerink Partners Downgrades Baxter International (BAX) to Market Perform

July 30, 2015 7:43 AM EDT

Leerink Partners downgraded Baxter International (NYSE: BAX) from Outperform to Market Perform with a price target of $40.00 (from $82.00).

Analyst Danielle Antalffy commented, "We are downgrading BAX shares to MP with a $40 12-month price target. Despite delivering solid 2Q15 results, post-split new BAX valuation appears lofty to us, already seeming to factor in potential upside in both sales... More

Baxter (BAX) Declares $0.115 Quarterly Dividend; 1.2% Yield

July 29, 2015 4:18 PM EDT

Baxter (NYSE: BAX) declared a quarterly dividend at a new rate of $0.115 per share, or $0.46 annualized, following its successful spin-off of its biopharmaceuticals business, Baxalta Incorporated.

The dividend will be payable on October 1, 2015, to stockholders of record on September 4, 2015, with an ex-dividend... More

Baxter (BAX) Tops Q2 EPS by 5c

July 29, 2015 4:16 PM EDT

Baxter (NYSE: BAX) reported Q2 EPS of $1.00, ex-items, $0.05 better than the analyst estimate of $0.95. Revenue for the quarter came in at $3.9 billion versus the consensus estimate of $3.77 billion.

Baxter sees Q3 2015 EPS of $0.29-$0.31, versus the consensus of $0.27.

''The... More